Table 2.
dWMH/pvWMH | Total WMH Volume | ||||||
---|---|---|---|---|---|---|---|
n | βs; β, [95% CI] | p | sr2 | βs; β, [95% CI] | p | sr2 | |
BMI | 1,825 | 0.056; 0.013 [0.002–0.023] | 0.018 | 0.0030 | 0.053; 0.013 [0.004–0.023] | 0.005 | 0.0024 |
WHR | 1,825 | 0.097; 1.01 [0.32–1.70] | 0.004 | 0.0044 | 0.11; 1.32 [0.71–1.9] | <10 –4 | 0.0054 |
Diastolic BP | 1,825 | 0.039; 0.004 [–0.001 to 0.008] | 0.095 | 0.0015 | 0.11; 0.012 [0.008–0.016] | <10 –7 | 0.0122 |
Systolic BP | 1,825 | 0.023; 0.001 [–0.001 to 0.004] | 0.35 | 0.0005 | 0.14; 0.009 [0.006–0.011] | <10 –11 | 0.0179 |
HbA1c | 1,825 | 0.026; 0.043 [–0.032 to 0.12] | 0.26 | 0.0007 | 0.04; 0.071 [0.004–0.14] | 0.038 | 0.0012 |
Smoking | 1,825 | –0.037; –0.078 [–0.17 to 0.02] | 0.12 | 0.0005 | 0.061; 0.087 [0.035–0.14] | 0.001 | 0.0033 |
CRP | 1,825 | 0.052; 0.052 [0.006–0.098] | 0.026 | 0.0026 | 0.043; 0.048 [0.008–0.089] | 0.019 | 0.0015 |
IL6 | 1,372 | 0.074; 0.11 [0.029–0.18] | 0.007 | 0.0051 | 0.046; 0.078 [0.008–0.15] | 0.029 | 0.0017 |
Deep WMH Volume | Periventricular WMH Volume | ||||||
BMI | 1,825 | 0.065; 0.012 [0.004–0.019] | 0.003 | 0.0038 | 0.036; 0.007 [4 × 10–4 to 0.014] | 0.065 | 0.0012 |
WHR | 1,825 | 0.12; 1.03 [0.53–1.53] | <10 –4 | 0.0069 | 0.092; 0.77 [0.32–1.23] | <10 –3 | 0.0038 |
BMIa | 1,825 | 0.035; 0.006 [0.001–0.12] | 0.017 | 0.0007 | –0.006; –0.001 [–0.006 to 0.004] | 0.63 | <10–4 |
WHRa | 1,825 | 0.80; 0.42 [0.76–0.83] | 0.018 | 0.0038 | 0.01; 0.086 [–0.23 to 0.4] | 0.60 | 0.0027 |
Statistical significant results are marked in bold.
Controlled additionally for periventricular WMH (in models with deep WMH as dependent variable) or for deep WMH (in models with periventricular WMH as dependent variable).
β = beta coefficient; βs = standardized coefficient; sr2 = semipartial correlation coefficient; BMI = body mass index; BP = blood pressure; CI = confidence interval; CRP = high‐sensitive C‐reactive protein; IL6 = interleukin‐6; WHR = waist‐to‐hip ratio.